This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Eli Lilly and Co (LLY)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 2.39B 4.68B 4.09B 4.35B
Operating Gains/Losses 145.60M 37.10M 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 117.40M -152.70M 361.80M -188.80M
(Increase) Decrease in Inventories -307.10M -286.50M -307.90M 203.10M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -260.70M -70.30M -336.10M 591.40M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 411.50M 116.50M 231.00M 642.70M
Other Non-Cash Items 527.30M -325.40M -320.80M 533.30M
Net Cash From Continuing Operations 4.37B 5.74B 5.30B 7.23B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 4.37B 5.74B 5.30B 7.23B
Sale of Property, Plant & Equipment 15.30M 179.40M 1.23B 25.30M
Cash Used for Investing Activities
Sale of Short-Term Investments 4.05B 3.32B 0.00 0.00
Purchases of Property, Plant & Equipment -1.47B -1.09B -1.04B -1.69B
Acquisitions -551.40M -43.70M -199.30M -307.80M
Purchases of Short-Term Investments -1.64B 0.00 0.00 0.00
Other Cash from Investing Activities -5.53B -1.63B 439.50M -528.10M
Cash Provided by Financing Activities
Net Cash From Investing Activities -3.91B -2.07B -2.83B -4.82B
Issuance of Debt 992.90M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 0.00 0.00 0.00
Repayment of Long-Term Debt -1.03B -10.50M -1.50B -54.60M
Repurchase of Capital Stock -800.00M -1.70B -721.10M 0.00
Payment of Cash Dividends -2.10B -2.12B -2.19B -2.18B
Other Financing Charges, Net 2.87B 0.00 -10.50M -135.20M
Net Cash From Financing Activities -75.10M -3.83B -4.42B -2.37B
Effect of Exchange Rate Changes -341.50M -21.50M 43.90M -110.90M
Net Change in Cash & Cash Equivalents 41.40M -188.60M -1.90B -70.70M
LLY News

LLY Eli Lilly and Co

Chart of LLY

Analysts Ratings for LLY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 7 7
Moderate Buy 0 0 0 1
Hold 5 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

LLY Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs